Business Context and Reporting Period
This Form 8-K filing by 22nd Century Group, Inc. (NASDAQ: XXII) covers events occurring on December 16, 2024, with a report date of December 17, 2024. The filing addresses critical corporate actions taken to address non-compliance with Nasdaq listing standards regarding minimum bid price requirements.
Key Financial Metrics and Capitalization
The filing does not provide revenue, profit, cash flow, or debt metrics. However, it details significant changes to the company's capitalization structure:
- Pre-Split Outstanding Shares: 74,724,641 shares (as of December 16, 2024).
- Post-Split Outstanding Shares: Approximately 553,516 shares (subject to rounding adjustments).
- Authorized Common Stock: Remains unchanged at 250,000,000 shares.
- Authorized Preferred Stock: Remains unchanged at 10,000,000 shares.
- Stock Price Trigger: The company's stock closed at $0.10 or less for 10 consecutive trading days ending December 13, 2024.
Material Changes Versus Prior Period
The primary material change is the execution of a 1-for-135 reverse stock split, effective December 17, 2024. This action was necessitated by the company's failure to maintain the $1.00 minimum bid price required by Nasdaq Listing Rule 5550(a)(2). Consequently, Nasdaq invoked the "Low Priced Stocks Rule" (Listing Rule 5810(c)(3)(A)(iii)), determining that the company's securities would be delisted from the Nasdaq Capital Market, overriding the previously granted 180-day cure period.
Guidance, Outlook, and Risks
Management Actions and Outlook:
- The company intends to appeal Nasdaq's delisting determination before a Hearings Panel by December 23, 2024.
- The appeal request stays the suspension of trading and delisting pending the panel's decision.
- The reverse stock split was approved by stockholders on December 6, 2024, and filed with the Nevada Secretary of State on December 16, 2024.
Risks and Contingencies:
- Delisting Risk: No assurance is provided that the company will obtain a favorable decision from the Hearings Panel or regain/maintain compliance with Nasdaq listing rules.
- Fractional Shares: No fractional shares or cash will be issued; holders of fractional amounts will receive one whole share.
- Trading Symbol: The stock will continue to trade under the symbol "XXII" but with a new CUSIP number (90137F400).
Investor Verification Checklist
- Verify the status of the appeal with the Nasdaq Hearings Panel and the expected timeline for a decision.
- Confirm the post-split share count and CUSIP number (90137F400) with brokerage accounts.
- Monitor the stock's bid price to ensure it meets the $1.00 minimum requirement following the split.
- Review the adjustment of outstanding options and warrants to ensure they reflect the 1-for-135 ratio.
- Check for any subsequent filings regarding the final outcome of the delisting appeal.